Study guide

12.5 Alternative ICU Delivery Models and Disaster Healthcare Management

Board Certified Critical Care Pharmacist Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pathophysiology and Recognition of Critical Illness

1.1 Pathophysiology of Shock and Sepsis 1.2 Respiratory Failure and ARDS Pathophysiology 1.3 ICU-Acquired Weakness and Post-Intensive Care Syndrome 1.4 Chronic Disease States and Risk Factors for Critical Illness

2 Chapter 2: Medical Devices and Circulatory Support

2.1 Hemodynamic Monitoring and Interpretation 2.2 Mechanical Circulatory Support 2.3 Mechanical Ventilation Modes and Settings 2.4 Continuous Renal Replacement Therapy 2.5 Lines, Tubes, and Drains in Critical Care

3 Chapter 3: Fluid, Electrolyte, and Acid-Base Management

3.1 Resuscitation Fluids: Crystalloids vs. Colloids 3.2 Electrolyte Disorders in the ICU 3.3 Acid-Base Disorders and Interpretation

4 Chapter 4: Vasoactive and Inotropic Therapy in Shock

4.1 Vasopressors in Distributive Shock 4.2 Inotropes and Vasopressors in Cardiogenic and Obstructive Shock

5 Chapter 5: Sedation, Analgesia, and Delirium (PADIS)

5.1 Pain and Analgesia in the ICU 5.2 Sedation Strategies and Medication Selection 5.3 Delirium Assessment, Prevention, and Treatment 5.4 Neuromuscular Blockade in Critical Illness

6 Chapter 6: Cardiovascular Emergencies

6.1 Acute Coronary Syndromes in ICU Patients 6.2 Acute Decompensated Heart Failure 6.3 Hypertensive Emergencies and Arrhythmias

7 Chapter 7: Pulmonary and Infectious Diseases in the ICU

7.1 Severe Sepsis and Septic Shock Antimicrobial Selection 7.2 Pharmacotherapy for Mechanical Ventilation and ARDS 7.3 Severe Infections in the ICU

8 Chapter 8: Neurocritical Care

8.1 Ischemic and Hemorrhagic Stroke Management 8.2 Intracranial Hypertension and Brain Edema 8.3 Status Epilepticus and Sedation in Brain Injury

9 Chapter 9: Toxicology, Endocrine, and Hematologic Emergencies

9.1 Toxicology and Antidote Therapy in the ICU 9.2 Endocrine Emergencies 9.3 Hematologic Emergencies, Anticoagulant Reversal, and Transfusions 9.4 Gastrointestinal and Hepatic Emergencies in the ICU 9.5 Dermatologic and Immunologic Conditions in the ICU 9.6 Trauma, Burns, Supportive Care, and End-of-Life Pharmacotherapy

10 Chapter 10: Special Populations, Pharmacokinetics, and Nutrition

10.1 Altered Pharmacokinetics in Critically Ill Patients 10.2 Therapeutic Drug Monitoring in the ICU 10.3 Nutrition Support: Enteral vs. Parenteral

11 Chapter 11: Quality, Safety, and Clinical Guidelines

11.1 Medication Safety and Error Prevention in the ICU 11.2 Antimicrobial Stewardship and Infection Prevention 11.3 Implementation of Clinical Practice Guidelines 11.4 Healthcare Regulations, Standards, and Drug Interactions

12 Chapter 12: Practice Management, Biostatistics, and Evidence-Based Medicine

12.1 ICU Formulary Management and Cost-Effectiveness 12.2 Biostatistics and Literature Evaluation 12.3 Clinical Trial Interpretation in Critical Care 12.4 Professional Development, Precepting, and ICU Pharmacy Services 12.5 Alternative ICU Delivery Models and Disaster Healthcare Management

13 Chapter 13: Treatment Planning and Care Coordination

13.1 Goals of Care, Perioperative Care, and Transitions of Care 13.2 Medication Delivery Routes and Devices in Critical Illness 13.3 Social Determinants of Health and Patient/Caregiver Education

12.5 Alternative ICU Delivery Models and Disaster Healthcare Management

Key Takeaways Explain This Topic AI

Tele-ICU (eICU) extends intensivist coverage to remote hospitals; pharmacist roles include remote order review, renal dose adjustment, antimicrobial stewardship, and 24/7 verification across multiple facilities.

Post-ICU clinics (ICU follow-up clinics) and ICU diaries reduce post-intensive care syndrome (PICS); pharmacist role includes medication reconciliation, deprescribing, and managing post-ICU sequelae.

Disaster pharmacotherapy requires mass casualty triage protocols, medication stockpiling (strategic national stockpile), antidote availability (cyanide, nerve agents, radiation), and crisis standards of care for ventilator allocation.

Emergency mass casualty antidotes include hydroxocobalamin (cyanide), atropine/pralidoxime (nerve agents), potassium iodide (radiation), and prussian blue (radioactive cesium/thallium); ICU pharmacists must know dosing and availability.

Last updated: July 2026

  • Alternative ICU Delivery Models and Disaster Healthcare Management
  • Alternative Healthcare Delivery Modalities (ECO 3B6)
  • Tele-ICU (eICU)

Tele-ICU programs deliver remote intensivist and nursing coverage to ICUs without 24/7 on-site presence. Models include:

Continuous centralized model: hub staffed 24/7 by intensivists, nurses, pharmacists monitoring multiple ICUs.

Periodic/episodic model: scheduled teleconsults for rounds or specific issues.

Reactive model: remote team responds to alerts or pages.

Pharmacist role in tele-ICU:

Remote order verification and renal dose adjustment across facilities.

24/7 antimicrobial stewardship via tele-stewardship rounds.

IV-to-PO conversion protocols.

Therapeutic drug monitoring (vancomycin AUC dosing) remotely.

Participation in multidisciplinary rounds and code response.

Documentation in shared EHR with state-specific licensure (interstate medical compact).

Outcomes: Meta-analyses show reduced ICU mortality and length of stay with continuous tele-ICU coverage; greatest benefit in smaller hospitals without 24/7 on-site intensivist.

Post-ICU Clinic and Recovery Programs

Post-intensive care syndrome (PICS) affects 50-80% of survivors with cognitive, psychological, and physical impairment. Post-ICU clinics (PICS clinics) provide multidisciplinary follow-up 2-4 weeks post-discharge.

Pharmacist role:

Comprehensive medication reconciliation.

Deprescribing of unnecessary post-ICU medications (PPIs started for SUP, anticoagulation no longer indicated, antipsychotics started for delirium).

Management of post-ICU sequelae: neuropathic pain (gabapentin), PTSD (SSRIs), insomnia (sleep hygiene first, then trazodone).

Education on chronic disease medications resumed after acute illness.

Coordination with primary care and specialists.

ICU diaries: written by nurses and family during ICU stay; reduce PTSD and anxiety post-discharge. Pharmacist can contribute entries about medication changes and sedation holds.

Long-Term Acute Care Hospitals (LTACH) and Step-Down Units

ICU step-down and LTACH transitions require structured handoffs including full medication list, antibiotic plans (duration, de-escalation), anticoagulation plan, TPN weaning, and goals-of-care conversations. Pharmacist-led transitions of care reduce medication errors.

  • Disaster Healthcare Management (ECO 3B7)
  • Mass Casualty Triage and Pharmacist Role

During mass casualty events (natural disaster, mass shooting, chemical release, radiation, biological attack), pharmacists support:

Medication supply chain and inventory surge.

Antidote identification and dosing.

Sterile compounding surge capacity.

Crisis standards of care: ventilator allocation, vasopressor triage.

Patient identification (medication reconciliation in chaos).

Pain and sedation in resource-limited settings.

Strategic National Stockpile (SNS)

CDC's SNS provides 12-hour push packages of essential medical supplies to states during public health emergencies. Contents include:

Antibiotics for anthrax/plague/tularemia post-exposure (ciprofloxacin, doxycycline).

Antivirals (oseltamivir for influenza surge).

Chemical antidotes (atropine, pralidoxime, midazolam for nerve agents).

Vaccines and antitoxins (botulism antitoxin heptavalent, smallpox vaccine).

Ventilators and PPE.

High-Yield Antidote Dosing for Mass Casualty

  • Threat Antidote Adult Dosing
  • Cyanide (smoke inhalation, chemical) Hydroxocobalamin 5 g IV over 15 min; repeat 5 g if severe

Nerve agents (sarin, VX) Atropine + Pralidoxime Atropine 2-6 mg IV q5-10 min until secretions dry; 2-PAM 600-1800 mg IM/IV

  • Radiation (iodine) Potassium iodide (KI) 130 mg PO daily x10 days (adults >40 only if high exposure)
  • Radioactive cesium/thallium Prussian blue 1 g PO TID x30 days
  • Heavy metals (lead, arsenic) Succimer (DMSA), dimercaprol (BAL), EDTA Per agent-specific protocols

Methanol/ethylene glycol Fomepizole 15 mg/kg IV load, then 10 mg/kg q12h x4 doses, then 15 mg/kg q12h until methanol <20 mg/dL and acidosis resolved

Opioid mass exposure (fentanyl analog) Naloxone 0.4-2 mg IV/IM; repeat as needed; continuous infusion 2/3 of effective dose per hour

  • Botulinum toxin Botulism antitoxin heptavalent (BAT) Per CDC protocol; obtain through state health department
  • Crisis Standards of Care

Per the Institute of Medicine (now National Academies) framework:

Fairness: transparent triage criteria.

Duty to care: maintain best possible care under constraints.

Duty to steward resources: ventilator allocation by survival probability.

Transparency: public and clinician understanding of altered standards.

Proportionality: restrictions scale to scarcity.

Accountability: documentation and review.

Pharmacist role: ensure medication allocation aligns with crisis standards, document decisions, support ethics committees.

Specific Disaster Pharmacotherapy Considerations

Pandemic surge (COVID/flu): corticosteroid use per guidelines (dexamethasone 6 mg daily x10 days for COVID-19 requiring oxygen), antiviral stewardship, anticoagulation prophylaxis adjusted to thrombotic risk.

Mass burns: antibiotic dosing per ARC (see 9.6), escharotomy pain control.

Crush injuries: rhabdomyolysis management with fluids, bicarbonate; mannitol not first-line.

Chemical exposures: decontamination before entering facility.

Nuclear/radiation: KI timing critical (effective within 4 hours of exposure).

Operational Preparedness

Antidote stocking: ASHP recommends stocking 24h supply of high-volume antidotes (hydroxocobalamin, fomepizole, naloxone, atropine); pharmacy director ensures quantity.

Disaster drill participation: pharmacist role in mass casualty exercises.

Emergency medication sets: pre-stocked code carts, smart pump libraries.

Alternative compounding: during IV shortage, identify oral alternatives, compounding from tablets, conservative dosing.

Clinical Scenario

A chemical plant explosion releases cyanide. Six victims arrive simultaneously with altered mental status, hypotension, and lactate >10 mmol/L. Hospital pharmacy stocks only 4 vials of hydroxocobalamin (5 g each). What is the appropriate response?

Answer: Cyanide toxicity from smoke or industrial exposure should be treated with hydroxocobalamin 5 g IV over 15 minutes per patient. With only 4 vials for 6 patients, immediately activate the strategic national stockpile (state health department emergency line) and request emergency resupply. Alternative: sodium thiososulfate (12.5 g IV) + sodium nitrite (300 mg IV) kit (Nithiodote) for adult patients without smoke inhalation (nitrites induce methemoglobinemia, dangerous in concomitant CO exposure). Initiate supportive care (100% oxygen, sodium bicarbonate for severe metabolic acidosis, vasopressors for hypotension). Document triage decisions per crisis standards of care.